Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism STAT5A inhibitors(Signal transducer and activator of transcription 5A inhibitors), STAT5B inhibitors(Signal transducer and activator of transcription 5B inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Philadelphia chromosome positive chronic myelogenous leukemia | Preclinical | United States | 05 Aug 2015 | |
| Prostatic Cancer | Preclinical | United States | 05 Aug 2015 |





